Pharnext

Pharnext Pharnext is an advanced clinical stage biopharmaceutical company based in France.

Hugo Brugière, gérant de Pharnext, a participé au Congrès annuel de l’association CMT-France et présenté les dernières d...
25/04/2024

Hugo Brugière, gérant de Pharnext, a participé au Congrès annuel de l’association CMT-France et présenté les dernières données de Phase III de PXT3003 dans la CMT1A.
Le replay de son intervention est disponible en ligne.

Lire notre communiqué : https://lnkd.in/eKK7dUEG

Pharnext  provides an update on the ongoing analysis of data from pivotal Phase III study (PREMIER trial) of PXT3003, it...
28/02/2024

Pharnext provides an update on the ongoing analysis of data from pivotal Phase III study (PREMIER trial) of PXT3003, its drug candidate in Charcot-Marie-Tooth disease type 1A (CMT1A).

Read our press release: https://bit.ly/3wxv1o9

Pharnext  fait un point d’étape sur l’analyse en cours des données de l'essai pivot de Phase III (essai PREMIER) de PXT3...
28/02/2024

Pharnext fait un point d’étape sur l’analyse en cours des données de l'essai pivot de Phase III (essai PREMIER) de PXT3003, son candidat médicament dans la maladie de Charcot-Marie-Tooth de type 1A (CMT1A).

Lire notre communiqué : https://bit.ly/3UYproK

30/01/2024

Charcot-Marie-Tooth symptoms include muscle weakness, muscle wasting, foot drop, CMT foot deformity, charcot marie tooth feet, and difficulty with fine motor skills in hands. These symptoms are caused by damage to the nerves that control muscle movement and sensation in the arms, legs, hands, and feet. Some other charcot-marie-tooth disease symptoms may include gastrointestinal problems, fatigue, tremors, sensory loss and neuropathic pain.
There are several different types of symptoms of CMT as well as many types of Charcot-Marie-Tooth CMT, including CMT1A, CMT2A, and HNPP. Each type of CMT is caused by a different genetic mutation. Therefore, CMT genetic testing can be used to diagnose CMT disease and determine which type a person has.
The Hereditary Neuropathy Foundation (HNF) is an organization that funds CMT research through the Therapeutic Research in Accelerated Discovery ( ) initiative which focuses on finding CMT treatments and cures, and includes a global CMT patient registry called the Global Registry for Inherited Neuropathies ( ). It also provides support and resources for people living with CMT and other hereditary neuropathies. HNF’s website, hnf-cure.org, provides valuable CMT resources for people seeking CMT support.
One of the most common treatments for CMT is the use of ankle-foot orthotics (AFOs) and other braces to support the feet and legs. Shoes for CMT can be found via a growing group of inclusive clothing brands. Knowing which CMT AFO is best for you can help with foot deformities and prevent falls. Physical therapy and CMT exercises can also benefit people with CMT. Vitamins for CMT patients and nutrition play important roles in daily function. Read more at..https://www.hnf-cure.org/patience-resources/newly-diagnosed/charcot-marie-tooth-disease-symptoms/

08/01/2024
08/01/2024
Pharnext  intends to prepare registration and marketing authorizationdo ssiers for PXT3003, its drug candidate in Charco...
19/12/2023

Pharnext intends to prepare registration and marketing authorizationdo ssiers for PXT3003, its drug candidate in Charcot-Marie-Tooth disease type 1A.

Read our press release: https://bit.ly/41xZy0f

Pharnext annonce son intention de préparer des dossiers d’enregistrement et d’autorisation de mise sur le marché de PXT3...
19/12/2023

Pharnext annonce son intention de préparer des dossiers d’enregistrement et d’autorisation de mise sur le marché de PXT3003, son candidat-médicament dans la maladie de Charcot-Marie-Tooth de type 1A.

Lire notre communiqué : https://bit.ly/3Tpm5dM

13/12/2023

One of our most important missions at HNF is to show people what it’s like to live with Charcot-Marie-Tooth Disease (CMT). Unfortunately, our disease is still relatively unknown to the general public.
The Essential Guide: What It’s Like To Live with Charcot-Marie-Tooth (CMT) -The Stories of Those Who Know Best, delves deep into the world of CMT and paints a vivid picture of some of the emotional, spiritual and psychological challenges that accompany the physical challenges brought on by this disease. Download guide @ https://www.hnf-cure.org/cmt/what-is-cmt/the-essential-cmt-guide/

Pharnext fait le point sur les premiers résultats de l’étude clinique pivot de Phase III (essai PREMIER) de PXT3003 dans...
11/12/2023

Pharnext fait le point sur les premiers résultats de l’étude clinique pivot de Phase III (essai PREMIER) de PXT3003 dans la maladie de Charcot-Marie-Tooth de type 1A, une neuropathie périphérique rare invalidante.

Lire notre communiqué de presse : https://bit.ly/47VDU8D

Adresse

14 Rue De La République
Suresnes
92150

Notifications

Soyez le premier à savoir et laissez-nous vous envoyer un courriel lorsque Pharnext publie des nouvelles et des promotions. Votre adresse e-mail ne sera pas utilisée à d'autres fins, et vous pouvez vous désabonner à tout moment.

Partager